Nexus AG

XETRA NXU.DE

Nexus AG EBIT Margin for the year ending December 31, 2023: 14.46%

Nexus AG EBIT Margin is 14.46% for the year ending December 31, 2023, a 6.83% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.
  • Nexus AG EBIT Margin for the year ending December 31, 2022 was 13.54%, a 5.62% change year over year.
  • Nexus AG EBIT Margin for the year ending December 31, 2021 was 12.81%, a 4.57% change year over year.
  • Nexus AG EBIT Margin for the year ending December 31, 2020 was 12.25%, a 3.56% change year over year.
  • Nexus AG EBIT Margin for the year ending December 31, 2019 was 11.83%, a 6.94% change year over year.
Key data
Date EBIT Margin EPS (Basic) EPS (Diluted) Shares (Basic, Weighted)
Market news
Loading...
XETRA: NXU.DE

Nexus AG

CEO Dr. Ingo Behrendt MBA
IPO Date July 24, 2000
Location Germany
Headquarters Irmastrasse 1
Employees 1,980
Sector Health Care
Industries
Description

Nexus AG develops and sells software and hardware solutions, and provides IT services, primarily for customers in the health care system worldwide. It operates in two divisions, Healthcare Software and Healthcare Services. The company offers information systems, such as NEXUS/HIS and KIS for somatic hospitals; NEXUS/PSYCHIATRY for psychiatric institutions; NEXUS/REHAB for rehabilitation facilities; ITR, a software for rehabilitation, clinics, and hotels with medical care; NEXUS/ARCHIVE and PEGASOS, an archiving and process management system; NEXUS/QM for quality management; NEXUS/INTEGRATION SERVER, an interface management; NEXUS/CLOUD IT, outsourcing solution; NEXUS/EPS, a software solution to supplement SAP personnel management, as well as process and HR consulting in the SAP environment; ifa systems, an ophthalmology software solution; Sophrona solutions, ophthalmology patients and referral program; and NEXUS/DIS, interdisciplinary diagnostic information system. Its information systems also comprise NEXUS/SWISSLAB, a laboratory information system; NEXUS/LAURIS for order communication in diagnostics; NEXUS/PATHOLOGY and NEXUS/CYTOLOGY for pathology and cytology institutes; dc-Pathos and dc-LabMan for pathology and cytology devices; NEXUS/RADIOLOGY, an information and image system for radiology wards and offices; NEXUs/CHILI, for PACS and teleradiology solutions; NEXUS/ASTRAIA for obstetrics and gynecology; NEXUS/SPECIAL DIAGNOSTICS and Clinic WinData for medical specialist diagnostics and device integration; NEXUS/HOME for senior citizen and nursing homes; NEXUS/OUTPATIENT CARE and Asebis, a homecare solution; NEXUS/PAT, an administration system for hospitals; and osoTEC for billing personal and other services. In addition, the company offers SINAPSI, highsystemNET, CREATIV OM, SEXTANT, Emed, NEXUS/EPD, NEXUS/AEMP, NEXUS/SPM, EuroSDS, RVS Software, NEXUS/VITA and TESIS VITA, and NEXUS/ESKULAP. NEXUS AG is headquartered in Donaueschingen, Germany.

Similar companies

AOF.DE

ATOSS Software AG

USD 111.31

-3.33%

COP.DE

CompuGroup Medical SE & Co. KGaA

USD 22.41

0.70%

MUM.DE

Mensch und Maschine Software SE

USD 54.00

-1.83%

COK.DE

Cancom SE

USD 23.50

-0.70%

IVU.DE

IVU Traffic Technologies AG

USD 15.72

1.94%

StockViz Staff

January 15, 2025

Any question? Send us an email